Serif Senturk
Dokuz Eylul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Correction: Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.
Journal: Cell death & disease
Published: April 24, 2026
A Nutrient-Sensitive ZRF1-Dependent Secretory Network Involving S100A9 Contributes to Neutrophil Plasticity in Triple-Negative Breast Cancer.
Journal: ACS pharmacology & translational science
Published: January 13, 2026
Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer.
Journal: Cell death & disease
Published: February 05, 2025
Modeling hepatic fibrosis in TP53 knockout iPSC-derived human liver organoids.
Journal: Molecular oncology
Published: December 09, 2024
The G protein-coupled receptor GPR89A is a novel potential therapeutic target to overcome cisplatin resistance in NSCLC Calu1 cells.
Journal: The FEBS journal
Published: June 25, 2024
Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma.
Journal: Cell death & disease
Published: January 23, 2024
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on bladder cancer cells.
Journal: Cancer gene therapy
Published: May 05, 2023
Differential Occupancy and Regulatory Interactions of KDM6A in Bladder Cell Lines.
Journal: Cells
Published: December 19, 2022
Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris.
Journal: Scientific reports
Published: December 12, 2022
Last Updated: 09/26/2026